These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4317229)

  • 1. Control of acute mycoplasmal and viral respiratory tract disease.
    Chanock RM
    Science; 1970 Jul; 169(3942):248-56. PubMed ID: 4317229
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization against respiratory virus infections.
    Hobson D
    Mod Trends Immunol; 1967; 2():53-85. PubMed ID: 4298139
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibilities of immunoprophylaxis of viral infections].
    Schierz G
    Munch Med Wochenschr; 1968 Mar; 110(12):693-6. PubMed ID: 4175272
    [No Abstract]   [Full Text] [Related]  

  • 4. The future of vaccines against viral diseases.
    Plotkin SA
    Pediatr Clin North Am; 1968 May; 15(2):447-72. PubMed ID: 4297640
    [No Abstract]   [Full Text] [Related]  

  • 5. [Basic directions in the prevention of influenza and other respiratory virus infections].
    Smorodintsev AA
    Vestn Akad Med Nauk SSSR; 1968; 23(9):3-10. PubMed ID: 4317585
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccines for the prevention of respiratory viral infections: problems and current status.
    Olszewska W; Helson R; Openshaw PJ
    Expert Opin Investig Drugs; 2004 Jun; 13(6):681-9. PubMed ID: 15174954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children.
    Kim HW; Arrobio JO; Brandt CD; Wright P; Hodes D; Chanock RM; Parrott RH
    Pediatrics; 1973 Jul; 52(1):56-63. PubMed ID: 4353352
    [No Abstract]   [Full Text] [Related]  

  • 8. Respiratory virus vaccines. V. Field evaluation for efficacy of heptavalent vaccine.
    Weibel RE; Stokes J; Leagus MB; Mascoli CC; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):362-79. PubMed ID: 4288226
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effects of inactive Mycoplasma pneumoniae vaccine in military personnel, 1964-1966.
    Mogabgab WJ
    Am Rev Respir Dis; 1968 Mar; 97(3):359-65. PubMed ID: 4867003
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infections with respiratory viruses].
    Popow-Kraupp T
    Ther Umsch; 1994 Aug; 51(8):563-8. PubMed ID: 7940414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental modifications for controlling acute respiratory disease.
    Lehane DE; Newberg NR; Beam WE
    Am J Epidemiol; 1974 Feb; 99(2):139-44. PubMed ID: 4359271
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of a "mixed bacterial vaccine" in prophylaxis of acute respiratory infections: possible role of interferon.
    Rytel MW; Ferstenfeld JE; Rose HD; Balay J; Pierce WE; Lynch KL
    Am J Epidemiol; 1974 May; 99(5):347-59. PubMed ID: 4151096
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective efficacy of killed Mycoplasma pneumoniae vaccine measured in large-scale studies in a military population.
    Mogabgab WJ
    Am Rev Respir Dis; 1973 Oct; 108(4):899-908. PubMed ID: 4582435
    [No Abstract]   [Full Text] [Related]  

  • 14. Report of a workshop: disease accentuation after immunization with inactivated microbial vaccines.
    Craighead JE
    J Infect Dis; 1975 Jun; 131(6):749-54. PubMed ID: 1169271
    [No Abstract]   [Full Text] [Related]  

  • 15. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.
    Fulginiti VA; Eller JJ; Sieber OF; Joyner JW; Minamitani M; Meiklejohn G
    Am J Epidemiol; 1969 Apr; 89(4):435-48. PubMed ID: 4305199
    [No Abstract]   [Full Text] [Related]  

  • 16. [PATHOGENIC VIRUSES OF THE RESPIRATORY TRACT AND THEIR METHODS OF IDENTIFICATION].
    PEROL Y
    Poumon Coeur; 1964; 20():1101-14. PubMed ID: 14250271
    [No Abstract]   [Full Text] [Related]  

  • 17. Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits.
    Pierce WE; Peckinpaugh RO; Frazier WE; Griffin JP; Greenberg BH; Jackson GG
    Antimicrob Agents Chemother (Bethesda); 1965; 5():55-8. PubMed ID: 4286921
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.
    Top FH; Buescher EL; Bancroft WH; Russell PK
    J Infect Dis; 1971 Aug; 124(2):155-60. PubMed ID: 4330998
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.
    Top FH; Dudding BA; Russell PK; Buescher EL
    Am J Epidemiol; 1971 Aug; 94(2):142-6. PubMed ID: 4327997
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenovirus vaccines in military recruit populations: a cost-benefit analysis.
    Collis PB; Dudding BA; Winter PE; Russell PK; Buescher EL
    J Infect Dis; 1973 Dec; 128(6):745-52. PubMed ID: 4358121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.